SEARCH

SEARCH BY CITATION

Literature Cited

  • Acconcia F, Ascenzi P, Fabozzi G, Visca P, Marino M. 2004. S-Palmitoylation modulates human estrogen receptor-[alpha] functions. Biochem Biophys Res Commun 316: 878883.
  • Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M. 2005. Palmitoylation-dependent estrogen receptor {alpha} membrane localization: Regulation by 17{beta}-estradiol. Mol Biol Cell 16: 231237.
  • Aguirre JI, Plotkin LI, Gortazar AR, Martin Millan M, O'Brien CA, Manolagas SC, Bellido T. 2007. A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction. J Biol Chem: M702231200.
  • Anderson RGW. 1998. The caveolae membrane system. Annu Rev Biochem 67: 199225.
  • Ballare C, Uhrig M, Bechtold T, Sancho E, Di Domenico M, Migliaccio A, Auricchio F, Beato M. 2003. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol Cell Biol 23: 19942008.
  • Barletta F, Wong C-W, McNally C, Komm BS, Katzenellenbogen B, Cheskis BJ. 2004. Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc. Mol Endocrinol 18: 10961108.
  • Boonyaratanakornkit V, Edwards DP. 2004. Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. Essays Biochem 40: 105120.
  • Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP. 2001. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8: 269280.
  • Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-A, Carlquist M. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753758.
  • Cabodi S, Moro L, Baj G, Smeriglio M, Di Stefano P, Gippone S, Surico N, Silengo L, Turco E, Tarone G, Defilippi P. 2004. p130Cas interacts with estrogen receptor {alpha} and modulates non-genomic estrogen signaling in breast cancer cells. J Cell Sci 117: 16031611.
  • Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H. 2001. PI3 kinase/AKT-mediated activation of estrogen receptor alpha: A new model for anti-estrogen resistance. J Biol Chem 276: 98179824.
  • Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein Fox A1. Cell 122: 3343.
  • Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F. 2001. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20: 60506059.
  • Castoria G, Lombardi M, Barone MV, Bilancio A, Di Domenico M, De Falco A, Varricchio L, Bottero D, Nanayakkara M, Migliaccio A, Auricchio F. 2004. Rapid signalling pathway activation by androgens in epithelial and stromal cells. Steroids 69: 517522.
  • Cenni B, Picard D. 1999. Ligand-independent activation of steroid receptors: New roles for old players. Trends Endocrinol Metab 10: 4146.
  • Chen D, Ma H, Hong H, Koh SS, Huang S-M, Schurter BT, Aswad DW, Stallcup MR. 1999. Regulation of transcription by a protein methyltransferase. Science 284: 21742177.
  • Chen J-R, Plotkin LI, Aguirre JI, Han L, Jilka RL, Kousteni S, Bellido T, Manolagas SC. 2004. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus Pro-apoptotic effects of estrogens. J Biol Chem 280: 46324638.
  • Cheskis BJ. 2004. Regulation of cell signalling cascades by steroid hormones. J Cell Biochem 93: 2027.
  • Cheskis BJ, McKenna NJ, Wong C-W, Wong J, Komm B, Lyttle CR, O'Malley BW. 2003. Hierarchical affinities and a bipartite interaction model for estrogen receptor isoforms and full-length steroid receptor coactivator (SRC/p160) family members. J Biol Chem 278: 1327113277.
  • Cheung E, Acevedo ML, Cole PA, Kraus WL. 2005. Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1. Proc Natl Acad Sci 102: 559564.
  • Cohen G, Ren R, Baltimore D. 1995. Modular binding domains in signal transduction proteins. Cell 80: 237248.
  • Committee NRN. 1999. A unified nomenclature of system for the nuclear receptor superfamily. Cell 97: 13.
  • Danielian PS, White R, Lees JA, Parker MG. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11: 10251033.
  • Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR. 1998. Structure and specificity of nuclear receptor–coactivator interactions. Genes Dev 12: 33433356.
  • Davies GC, Huster WJ, Lu Y, Plouffe LEO, Jr., Lakshmanan M. 1999. Adverse events reported by postmenopausal women in controlled trials with raloxifene. Obstet Gynecol 93: 558565.
  • Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H, Korach KS, Sonntag-Buck V, Gannon F. 2001. ER{alpha} gene expression in human primary osteoblasts: Evidence for the expression of two receptor proteins. Mol Endocrinol 15: 20642077.
  • DiDomenico M, Castoria G, Bilancio A, Migliaccio A, Auricchio F. 1996. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56: 45164521.
  • Duan R, Xie W, Burghardt RC, Safe S. 2001. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J Biol Chem 276: 1159011598.
  • Duan R, Xie W, Li X, McDougal A, Safe S. 2002. Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. Biochem Biophys Res Commun 294: 384394.
  • Edwards D. 2004. Regulation of Signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 67: 335376.
  • Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, Kato S, Kawashima H. 1997. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 235: 99102.
  • Evans RM. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889895.
  • Feng W, Webb P, Nguyen P, Liu X, Li J, Karin M, Kushner PJ. 2001. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Mol Endocrinol 15: 3245.
  • Figtree GA, McDonald D, Watkins H, Channon KM. 2003. Truncated estrogen receptor {alpha} 46-kDa isoform in human endothelial cells: Relationship to acute activation of nitric oxide synthase. Circulation 107: 120126.
  • Filardo EJ, Quinn JA, Bland KI, Frackelton AR, Jr. 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14: 16491660.
  • Force USPST. 2002. Chemoprevention of breast cancer: Recommendations and rationale. Ann Intern Med 137: 5658.
  • Frasor J, Chang EC, Komm B, Lin C-Y, Vega VB, Liu ET, Miller LD, Smeds J, Bergh J, Katzenellenbogen BS. 2006. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res 66: 73347340.
  • Garcia Dos Santos E, Dieudonne MN, Pecquery R, Le Moal V, Giudicelli Y, Lacasa D. 2002. Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 143: 930940.
  • Gianni M, Bauer A, Garattini E, Chambon P, Rochette-Egly C. 2002. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation. EMBO J 21: 37603769.
  • Glass CK, Rosenfeld MG, Rose DW, Kurokawa R, Kamei Y, Xu L, Torchia J, Ogliastro MH, Westin S. 1997. Mechanisms of transcriptional activation by retinoic acid receptors. Biochem Soc Trans 25: 602605.
  • Glidewell-Kenney C, Hurley LA, Pfaff L, Weiss J, Levine JE, Jameson JL. 2007. Nonclassical estrogen receptor {alpha} signaling mediates negative feedback in the female mouse reproductive axis. Proc Natl Acad Sci 104: 81738177.
  • Goldstein SR, Scheele WH, Rajagopalan SK, Wilkie JL, Walsh BW, Parsons AK. 2000. A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium. Obstet Gynecol 95: 95103.
  • Greger JG, Fursov N, Cooch N, McLarney S, Freedman LP, Edwards DP, Cheskis BJ. 2007. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase. Mol Cell Biol 27: 19041913.
  • Groothuis PG, Dassen HHNM, Romano A, Punyadeera C. 2007. Estrogen and the endometrium: Lessons learned from gene expression profiling in rodents and human. Hum Reprod Update 13: 405417.
  • Gruber D, Huber J. 1999. Conjugated estrogens—The natural SERMs. Gynecol Endocrinol 13: 912.
  • Heery DM, Kalkhoven E, Hoare S, Parker MG. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors [see comments]. Nature 387: 733736.
  • Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson J-A. 2007. Estrogen receptors: How do they signal and what are their targets. Physiol Rev 87: 905931.
  • Hewitt SC, Harrell JC, Korach KS. 2005. Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 67: 285308.
  • Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. 1982. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635641.
  • Hu X, Lazar MA. 1999. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402: 9396.
  • Hubbard SR, Mohammadi M, Schlessinger J. 1998. Autoregulatory mechanisms in protein-tyrosine kinases. J Biol Chem 273: 1198711990.
  • Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Heart Estrogen/progestin Replacement Study Research G. 1998. Randomized Trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605613.
  • Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS. 1992. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci 89: 46584662.
  • Jakacka M, Ito M, Weiss J, Chien P-Y, Gehm BD, Jameson JL. 2001. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276: 1361513621.
  • Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, Jameson JL. 2002. An estrogen receptor (ER){alpha} deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 16: 21882201.
  • Jensen EV, DeSombre ER. 1973. Estrogen-receptor interaction. Science 182: 126134.
  • Johnston SR, Lu B, Scott GK, Kushner PJ, Smith IE, Dowsett M, Benz CC. 1999. Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Clin Cancer Res 5: 251256.
  • Joung I, Strominger JL, Shin J. 1996. Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. Proc Natl Acad Sci 93: 59915995.
  • Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. 2000. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275: 1844718453.
  • Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME. 2001. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 89: 534539.
  • Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H., et al. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 14911494.
  • Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, Clark AG, Kraus WL. 2007. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol Cell Biol 27: 50905104.
  • Koide A, Zhao C, Naganuma M, Abrams J, Deighton-Collins S, Skafar DF, Koide S. 2007. Identification of regions within the F domain of the human estrogen receptor {alpha} that are important for modulating transactivation and protein–protein interactions. Mol Endocrinol 21: 829842.
  • Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC. 2001. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104: 719730.
  • Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. 1996. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 59255930.
  • Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors {alpha} and {beta}. Endocrinology 138: 863870.
  • Kumar V, Chambon P. 1988. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145156.
  • Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. 1987. Functional domains of the human estrogen receptor. Cell 51: 941951.
  • Kumar P, Wu Q, Chambliss KL, Yuhanna IS, Mumby SM, Mineo C, Tall GG, Shaul PW. 2007. Direct interactions with G{alpha}i and G{beta}{gamma} mediate nongenomic signaling by estrogen receptor {alpha}. Mol Endocrinol 21: 13701380.
  • Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P. 2000. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74: 311317.
  • Lange CA, Shen T, Horwitz KB. 2000. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci 97: 10321037.
  • Lange CA, Gioeli D, Hammes SR, Marker PC. 2007. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol 69.
  • Lees JA, Fawell SE, Parker MG. 1989a. Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor. J Steroid Biochem 34: 3339.
  • Lees JA, Fawell SE, Parker MG. 1989b. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res 17: 54775488.
  • Levin ER. 2002. Cellular functions of plasma membrane estrogen receptors. Steroids 67: 471475.
  • Levin ER. 2003. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17: 309317.
  • Levin ER. 2005. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19: 19511959.
  • Li L, Haynes MP, Bender JR. 2003. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci 100: 48074812.
  • Longo M, Brama M, Marino M, Bernardini S, Korach KS, Wetsel WC, Scandurra R, Faraggiana T, Spera G, Baron R. 2004. Interaction of estrogen receptor [alpha] with protein kinase C [alpha] and c-Src in osteoblasts during differentiation. Bone 34: 100111.
  • Lopez GN, Turck CW, Schaufele F, Stallcup MR, Kushner PJ. 2001. Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J Biol Chem 276: 2217722182.
  • Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL. 1992. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326: 852856.
  • Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH. 2004. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor {alpha}. Proc Natl Acad Sci 101: 1712617131.
  • Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835839.
  • Margueron R, Trojer P, Reinberg D. 2005. The key to development: Interpreting the histone code? Curr Opin Genet Dev 15: 163176.
  • Marquez D, Pietras RJ. 2001. Membrane-associated binding sites for estrogen contribute to growth regulation in human breast cancer cells. Oncogene 20: 54205430.
  • Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179185.
  • Maurer RA, Notides AC. 1987. Identification of an estrogen-responsive element from the 5′-flanking region of the rat prolactin gene. Mol Cell Biol 7: 42474254.
  • McInerney EM, Rose DW, Flynn SE, Westin S, Mullen T-M, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12: 33573368.
  • McKenna NJ, O'Malley BW. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465474.
  • McKenna NJ, Lanz RB, O'Malley BW. 1999. Nuclear receptor coregulators: Cellular and molecular biology. Endocr Rev 20: 321344.
  • Mendelsohn ME, Karas RH. 2007. HRT and the young at heart. N Engl J Med 356: 26392641.
  • Mendez P, Azcoitia I, Garcia-Segura LM. 2003. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Mol Brain Res 112: 170176.
  • Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F. 2003. Estrogen receptor-[alpha] directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751763.
  • Metzger D, White JH, Chambon P. 1988. The human oestrogen receptor functions in yeast. Nature 334: 3136.
  • Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D, Chambon P. 1989. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57: 433442.
  • Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 12921300.
  • Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchio F. 1998. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17: 20082018.
  • Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F. 2000. Steroid-induced androgen receptor-oestradiol receptor {beta}-Src complex triggers prostate cancer cell proliferation. EMBO J 19: 54065417.
  • Migliaccio A, Castoria G, Di DomeniIco M, De Falco A, Bilancio A, Auricchio F. 2002. Src is an initial target of sex steroid hormone action. Ann NY Acad Sci 963: 185190.
  • Migliaccio A, Di Domenico M, Castoria G, Nanayakkara M, Lombardi M, de Falco A, Bilancio A, Varricchio L, Ciociola A, Auricchio F. 2005. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: Steroid antagonist action 10.1158/0008-5472.CAN-05-0912. Cancer Res 65: 1058510593.
  • Migliaccio A, Castoria G, Domenico MD, Ciociola A, Lombardi M, De Falco A, Nanayakkara M, Bottero D, De Stasio R, Varricchio L, Auricchio F. 2006. Crosstalk between EGFR and extranuclear steroid receptors. Ann NY Acad Sci 1089: 194200.
  • Montano MM, Muller V, Trobaugh A, Katzenellenbogen BS. 1995. The carboxy-terminal F domain of the human estrogen receptor: Role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol Endocrinol 9: 814825.
  • Mosselman S, Polman J, Dijkema R. 1996. ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 4953.
  • Naciff JM, Overmann GJ, Torontali SM, Carr GJ, Khambatta ZS, Tiesman JP, Richardson BD, Daston GP. 2007. Uterine temporal response to acute exposure to 17{alpha}-ethinyl estradiol in the immature rat. Toxicol Sci 97: 467490.
  • Nagy L, Kao H-Y, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373380.
  • Norman AW, Mizwicki MT, Norman DPG. 2004. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3: 2741.
  • O'Brien JE, Peterson TJ, Tong MH, Lee E-J, Pfaff LE, Hewitt SC, Korach KS, Weiss J, Jameson JL. 2006. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor {alpha} binding to classical estrogen response elements. J Biol Chem 281: 2668326692.
  • O'Malley BW. 2007. Coregulators: From whence came these 'master genes'. Mol Endocrinol me.2007-0012.
  • Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanlan TS. 1997. Differential ligand activation of estrogen receptors ER{alpha} and ER at AP1 sites. Science 277: 15081510.
  • Pedram A, Razandi M, Levin ER. 2006. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20: 19962009.
  • Pelicci G, Dente L, De Giuseppe A, Verducci-Galletti B, Giuli S, Mele S, Vetriani C, Giorgio M, Pandolfi PP, Cesareni G, Pelicci PG. 1996. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene 13: 633641.
  • Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER. 2002. ERs associate with and regulate the production of caveolin: Implications for signaling and cellular actions. Mol Endocrinol 16: 100115.
  • Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ER[alpha] on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11: 695707.
  • Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. 2005. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 16251630.
  • Robert W Miller JHR. 1995. Tumors in Rubinstein-Taybi syndrome. Am J Med Genet 56: 112115.
  • Rochette-Egly C. 2003. Nuclear receptors: Integration of multiple signalling pathways through phosphorylation. Cell Signal 15: 355366.
  • Rosenfeld MG, Lunyak VV, Glass CK. 2006. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20: 14051428.
  • Rowan BG, Weigel NL, O'Malley BW. 2000. Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275: 44754483.
  • Rutqvist LE, Anders Mattsson for the Stockholm Breast Cancer Study G. 1993. Cardiac and thromboembolic morbidity among postmenopausal women with early stage breast cancer in a randomized trial of adjuvant tamoxifen. J Natl Cancer Inst 85: 13981406.
  • Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD. 2002. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 17: 110.
  • Savouret JF, Bailly A, Misrahi M, Rauch C, Redeuilh G, Chauchereau A, Milgrom E. 1991. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J 10: 18751883.
  • Schule R, Umesono K, Mangelsdorf DJ, Bolado J, Pike JW, Evans RM. 1990. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61: 497504.
  • Selye H. 1942. Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 30: 437453.
  • Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, Collins T. 1999. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 19: 63676378.
  • Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. 1998. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927937.
  • Shupnik MA. 2004. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: Implications for cell proliferation. Oncogene 23: 79797989.
  • Song RX-D, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ. 2002. Linkage of rapid estrogen action to MAPK activation by ER{alpha}-Shc association and Shc pathway activation. Mol Endocrinol 16: 116127.
  • Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. 2004. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor {alpha} to the plasma membrane. Proc Natl Acad Sci 101: 20762081.
  • Spiegelman BM, Heinrich R. 2004. Biological control through regulated transcriptional coactivators. Cell 119: 157167.
  • Stender JD, Frasor J, Komm B, Chang KCN, Kraus WL, Katzenellenbogen BS. 2007. Estrogen regulated gene networks in human breast cancer cells: Involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol me.2006-0474.
  • Syed FA, Modder UIL, Fraser DG, Spelsberg TC, Rosen CJ, Krust A, Chambon P, Jameson JL, Khosla S. 2005. Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways. J Bone Miner Res 20: 19922001.
  • Syed FA, Fraser DG, Spelsberg TC, Rosen CJ, Krust A, Chambon P, Jameson JL, Khosla S. 2007. Effects of loss of classical estrogen response element signaling on bone in male mice. Endocrinology 148: 19021910.
  • Thomas P, Pang Y, Filardo EJ, Dong J. 2004. Identity of an estrogen membrane receptor coupled to a G-protein in human breast cancer cells. Endocrinology 146: 26242632.
  • Toft D, Gorski J. 1966. A receptor molecule for estrogens: Isolation from the rat uterus and preliminary characterization. Proc Natl Acad Sci USA 55: 15741581.
  • Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG. 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387: 677684.
  • Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V. 1997. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 11: 353365.
  • Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. 2006. Complex actions of sex steroids in adipose, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev 27: 575605.
  • Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T. 1994. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269: 1643316442.
  • Vadlamudi RK, Wang RA, Mazumdar A, Kim Y, Shin J, Sahin A, Kumar R. 2001. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem 276: 3827238279.
  • Vignon F, Bouton MM, Rochefort H. 1987. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146: 15021508.
  • Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M, Chambon P. 1985. Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 82: 78897893.
  • Watson CS, Gametchu B. 2003. Proteins of multiple classes may participate in nongenomic steroid actions. Exp Biol Med 228: 12721281.
  • Watson CS, Campbell CH, Gametchu B. 1999. Membrane oestrogen receptors on rat pituitary tumour cells: Immuno-identification and responses to oestradiol and xenoestrogens. Exp Physiol 84: 10131022.
  • Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM. 1997. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138: 40304033.
  • Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson J-A, Nilsson S, Kushner PJ. 1999. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13: 16721685.
  • Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ. 2000. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 14: 19761985.
  • Weisz A, Rosales R. 1990. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucl Acids Res 18: 50975106.
  • Welshons W, Cormier E, Wolf M, Williams PJ, Jordan V. 1988. Estrogen receptor distribution in enucleated breast cancer cell lines. Endocrinology 122: 23792386.
  • Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. 2002. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99: 1478314788.
  • Writing Group for the Women's Health Initiative I. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA 288: 321333.
  • Wu R-C, Qin J, Yi P, Wong J, Tsai SY, Tsai M-J, O'Malley BW. 2004. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell 15: 937949.
  • Zajchowski DA, Kauser K, Zhu D, Webster L, Aberle S, White FA III, Liu H-L, Humm R, MacRobbie J, Ponte P, Hegele-Hartung C, Knauthe R, Fritzemeier K-H, Vergona R, Rubanyi GM. 2000. Identification of selective estrogen receptor modulators by their gene expression fingerprints. J Biol Chem 275: 1588518453.
  • Zanello LP, Norman AW. 2004. Rapid modulation of osteoblast ion channel responses by 1{alpha},25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci 101: 15891594.
  • Zhao L, O'Neill K, Diaz Brinton R. 2005. Selective estrogen receptor modulators (SERMs) for the brain: Current status and remaining challenges for developing NeuroSERMs. Brain Res Rev 49: 472493.
  • Zivadinovic D, Watson C. 2005. Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 7: R130R144.